Please assess the completion status of the following clinical trial:

Trial Title: Cholecalciferol (Vitamin D3) Therapy in Chronic Kidney Disease (CKD) Subjects

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Age 18-85~* CKD stage 3-4 (GFR 15-59 ml/min/1.73 m2 body surface area, calculated by using the MDRD Study equation GFR Calculator)~* serum 25(OH)D concentrations ≤ 30 ng/mL, and serum PTH levels \>70 pg/mL documented within the last six months~Exclusion Criteria:~* History of liver failure (serum AST or ALT \> 3-fold the upper limit of normal)~* requiring dialysis at any stage of the study~* history of intestinal malabsorption or chronic diarrhea~* serum calcium level (corrected for serum albumin) \> 10.5 mg/dL~* calcium x phosphorus product \>70~* treatment with more than 1000 IU of vitamin D per day, or current treatment with a vitamin D analogue or calcimimetic~* an anti-epileptic medication and other medications which can affect vitamin D metabolism (e.g., phenobarbital, phenytoin, rifampicin)

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 85 Years
- Healthy Volunteers: f

Study Arms:
- Placebo (Type: PLACEBO_COMPARATOR): Placebo
- Cholecalciferol (Type: ACTIVE_COMPARATOR): D3

Based on this trial design, predict the completion outcome and termination type (if applicable).